Med Life SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: ROMEDLACNOR6
RON
6.89
-26.51 (-79.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
777.63
736.91
668.27
663.78
646.62
583.02
561.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
777.63
736.91
668.27
663.78
646.62
583.02
561.21
Raw Material Cost
689.07
668.33
595.51
583.48
568.14
526.60
505.43
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
191.85
185.57
167.35
160.61
155.94
145.52
145.70
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
23.98
24.03
27.28
26.55
24.77
24.78
22.63
Selling and Distribution Expenses
44.68
43.32
39.92
45.14
38.41
39.66
32.73
Other Expenses
-21.58
-20.96
-19.46
-18.72
-18.07
-17.03
-16.83
Total Expenditure (Excl Depreciation)
733.75
711.65
635.42
628.62
606.55
566.26
538.16
Operating Profit (PBDIT) excl Other Income
43.9
25.299999999999997
32.8
35.2
40.099999999999994
16.8
23
Other Income
-0.85
0.78
3.84
1.68
3.85
-2.37
2.76
Operating Profit (PBDIT)
112.13
103.62
98.92
95.22
100.30
70.88
74.69
Interest
23.98
24.03
27.28
26.55
24.77
24.78
22.63
Exceptional Items
-1.49
-0.81
-0.48
-0.38
-0.09
-0.49
-0.28
Gross Profit (PBDT)
88.56
68.57
72.76
80.30
78.48
56.42
55.78
Depreciation
69.09
77.58
62.24
58.39
56.38
56.49
48.88
Profit Before Tax
17.56
1.19
8.92
9.90
19.06
-10.87
2.90
Tax
7.00
5.27
5.54
5.56
5.96
-2.90
4.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
13.38
-0.11
4.74
5.94
14.46
-3.44
1.08
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
13.38
-0.11
4.74
5.94
14.46
-3.44
1.08
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.82
-3.96
-1.36
-1.61
-1.36
-4.53
-2.28
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10.56
-4.08
3.38
4.34
13.11
-7.97
-1.20
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.25
0.25
0.25
0.25
0.25
0.25
0.25
Reserves
445.16
432.63
439.39
434.72
429.22
415.29
423.01
Earnings per share (EPS)
0.03
-0.0
0.01
0.01
0.03
-0.01
0.0
Diluted Earnings per share
0.03
-0.0
0.01
0.01
0.03
-0.01
0.0
Operating Profit Margin (Excl OI)
5.64%
3.43%
4.92%
5.3%
6.2%
2.88%
4.11%
Gross Profit Margin
11.14%
10.69%
10.65%
10.29%
11.67%
7.83%
9.23%
PAT Margin
1.72%
-0.02%
0.71%
0.9%
2.24%
-0.59%
0.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2025 is 5.52% vs 10.26% in Dec 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2025 is 358.54% vs -220.59% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2025 is 9.92% vs 8.10% in Dec 2024

stock-summary

Interest

QoQ Growth in quarter ended Mar 2025 is 0.00% vs -12.09% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024

Compare Quarterly Results Of Med Life SA With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(RON)
Change(%)
Net Sales
777.63
0
777.63
Other Operating Income
0.00
0.00
0.00
Total Operating income
777.63
0
777.63
Raw Material Cost
689.07
0
689.07
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
191.85
0
191.85
Power Cost
0
0
0.00
Manufacturing Expenses
23.98
0
23.98
Selling and Distribution Expenses
44.68
0
44.68
Other Expenses
-21.58
0.00
-21.58
Total Expenditure (Excl Depreciation)
733.75
0
733.75
Operating Profit (PBDIT) excl Other Income
43.89
0.00
43.89
Other Income
-0.85
0
-0.85
Operating Profit (PBDIT)
112.13
0
112.13
Interest
23.98
0
23.98
Exceptional Items
-1.49
0
-1.49
Gross Profit (PBDT)
88.56
0
88.56
Depreciation
69.09
0
69.09
Profit Before Tax
17.56
0
17.56
Tax
7.00
0
7.00
Provisions and contingencies
0
0
0.00
Profit After Tax
13.38
0
13.38
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
13.38
0
13.38
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.82
0
-2.82
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10.56
0
10.56
Equity Capital
0
0
0.00
Face Value
0.25
0
0.00
Reserves
445.16
0
445.16
Earnings per share (EPS)
0.03
0
0.03
Diluted Earnings per share
0.03
0
0.03
Operating Profit Margin (Excl OI)
5.64%
0%
0.00
5.64%
Gross Profit Margin
11.14%
0%
0.00
11.14%
PAT Margin
1.72%
0%
0.00
1.72%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 77.76 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 5.52% vs 10.26% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 20.26% vs 22.12% in Mar 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.06 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 358.54% vs -220.59% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is -19.08% vs 55.95% in Mar 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.30 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 9.92% vs 8.10% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 17.10% vs 33.84% in Mar 2024

Quarterly - Interest
Interest 2.40 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 0.00% vs -12.09% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is -3.23% vs 63.16% in Mar 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.64%
in Mar 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 has fallen from Mar 2024